建行信用卡jcb什么意思sesen Bio Inc公司介绍
| 证券代码： |
SESN |
上市板： |
主板 |
| 证券名称： |
Sesen Bio Inc |
上市场所： |
纳斯达克交易所 |
| 证券类型： |
普通股 |
发行方式： |
公开发售 |
| 首发上市日： |
2014/02/06 |
首发价格(元)： |
10 |
| 首发数量(股)： |
5,000,000 |
首发募资总额(USD/元)： |
50,000,000.00 |
Sesen Bio Inc基本资料
| 公司名称： |
Sesen Bio, Inc. |
注册地址： |
美国特拉华州 |
| 证券名称： |
Sesen Bio Inc |
上市场所： |
纳斯达克交易所 |
| 办公地址： |
245 First Street, Suite 1800, C 建行信用卡jcb什么意思ambridge, Massachusetts, USA |
| 董事会主席： |
- |
成立日期： |
2008/02/25 |
| 公司属地： |
United States 美国 |
电话： |
+1 (617) 444-8550 |
| 公司网址： |
www.sesenbio.com |
| 公司介绍： |
Sesen Bio, Inc.'s current name was changed from Eleven Biotherapeutics, Inc. effective on Ma 建行信用卡jcb什么意思y 17, 2018. Eleven Biotherapeutics, Inc. is a late-stage clinical oncology company advancing a broad pipeline of novel product candidates based upon the Company’s TPT platform. The Company’s TPTs incorporate a tumor-targeting antibody fragment and a protein cytotoxic payload into a single protein molecule in order to achieve focused tumor cell killing. The Company believes its TPT approach offers significant advantages in treating cancer over existing ADC technologies. The Company believes its TPTs provide effective tumor targeting with broader cancer cell-killing properties than are achievable with small molecule payloads that require tumor cell proliferation and face multi-drug resistance mechanisms. Additionally, the Company believes that its TPT’s cancer cell-killing properties promote an anti-tumor immune response that will potentially combine well with immuno-oncology drugs such as checkpoint inhibitors. |
本文来自投稿，不代表本人立场，如若转载，请注明出处：http://www.smctrader.com/gupiaopeizi/117144.html
本站所有数据资料均来自第三方，仅作为用户获取信息，不构成投资建议，SMC股票学习网不为内容负责。
标签：
Sesen Bio Inc公司档案
SESN
SESN基金净值
SESN股吧
Sesen Bio Inc股票代码
SESN股票行情
Sesen Bio Inc公司概况
SESN股票